Search

Your search keyword '"Jade Bryant"' showing total 19 results

Search Constraints

Start Over You searched for: Author "Jade Bryant" Remove constraint Author: "Jade Bryant"
19 results on '"Jade Bryant"'

Search Results

1. Stratified analyses refine association between TLR7 rare variants and severe COVID-19

2. Characteristics and Outcome of Severe Mycoplasma pneumoniae Pneumonia Admitted to PICU in Shanghai: A Retrospective Cohort Study

3. Supplementary Table 7 from Kinase Pathway Dependence in Primary Human Leukemias Determined by Rapid Inhibitor Screening

4. Supplementary Table 4 from Kinase Pathway Dependence in Primary Human Leukemias Determined by Rapid Inhibitor Screening

5. Supplementary Table 1 from Kinase Pathway Dependence in Primary Human Leukemias Determined by Rapid Inhibitor Screening

6. Supplementary Table 3 from Kinase Pathway Dependence in Primary Human Leukemias Determined by Rapid Inhibitor Screening

7. Supplementary Table 6 from Kinase Pathway Dependence in Primary Human Leukemias Determined by Rapid Inhibitor Screening

8. Sweave Document from Kinase Pathway Dependence in Primary Human Leukemias Determined by Rapid Inhibitor Screening

9. Supplementary Table 2 from Kinase Pathway Dependence in Primary Human Leukemias Determined by Rapid Inhibitor Screening

10. Supplementary Figures 1-4 from Kinase Pathway Dependence in Primary Human Leukemias Determined by Rapid Inhibitor Screening

11. Supplementary Legends for Tables 1-4 and Figures 1-7 from Kinase Pathway Dependence in Primary Human Leukemias Determined by Rapid Inhibitor Screening

12. Integrative Analysis of Drug Response and Clinical Outcome in Acute Myeloid Leukemia

13. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

14. Functional genomic landscape of acute myeloid leukaemia

15. Kinase Pathway Dependence in Primary Human Leukemias Determined by Rapid Inhibitor Screening

16. Philadelphia Chromosome (Ph)-Positive Leukemia Patients Who Fail ABL1 Tyrosine Kinase Inhibitors Without BCR-ABL1 Kinase Domain Point Mutations Demonstrate Sensitivity To PI3-K/AKT Inhibitors

17. Partially or Fully BCR-ABL Independent Mechanisms of in Vitro Resistance to Ponatinib

18. CX-4945, An Orally Bioavailable Selective Inhibitor of Casein Kinase 2 (CK2), Exhibits Anti-Tumor Activity in Hematologic Malignancies

19. YM155 potently kills acute lymphoblastic leukemia cells through activation of the DNA damage pathway

Catalog

Books, media, physical & digital resources